Harrow (HROW) Current Taxes (2026)
Harrow (HROW) posted Current Taxes of $2.6 million for Q1 2026.
Powered by 
Analysis
Harrow (HROW) Current Taxes (2026) Analysis & Trends
Harrow has reported Current Taxes for 1 years, with the latest figure at $2.6 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | - |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 653.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.03 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | - |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Harrow | 1.41 Bn | 1.33 Bn | 50.36 Mn | - |